Anika Therapeutics (ANIK) Reports In-Line Q2 EPS of $0.08

July 22, 2009 4:19 PM EDT Send to a Friend

Anika Therapeutics (Nasdaq: ANIK) reports Q2 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Anika Therapeutics (ANIK) Reports In-Line Q2 EPS of $0.08

Member Login

Free News Feed